Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
264.3 EUR | +0.76% | -4.27% | +10.35% |
Mar. 26 | Transcript : Sartorius Stedim Biotech S.A. - Shareholder/Analyst Call | |
Mar. 12 | SARTORIUS STEDIM BIOTECH : Jefferies remains its Buy rating | ZD |
Evolution of the average Target Price on Sartorius Stedim Biotech
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
Consensus detail
Consensus revision (last 18 months)
Analysts covering Sartorius Stedim Biotech
JEFFERIES | James Vane-Tempest |
alphavalue | Virendra Chauhan |
CREDIT SUISSE | Dominic Lunn |
JPMORGAN | Richard Vosser |
UBS | Michael Leuchten |
HSBC | Rajesh Kumar |
BERENBERG | Odysseas Manesiotis |
EPS Revisions
- Stock
- Equities
- Stock Sartorius Stedim Biotech - Euronext Paris
- Consensus Sartorius Stedim Biotech